ArticleJournal of nanobiotechnology2026
Carnosic acid-loaded stimuli-responsive hydrogel promotes wound healing through PGP-1 mediated immune remodeling.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Persistent inflammation is a major barrier to effective wound healing. The local immune microenvironment, closely associated with the inflammatory state, exerts central regulatory control throughout repair. Pyroglutamyl aminopeptidase 1 (PGP-1) is implicated in inflammation-related conditions, but its role in wound inflammation and regeneration remains unclear. Here, carnosic acid (CA) was identified as a potent PGP-1 inhibitor that reduced the production of pro-inflammatory cytokines and promoted M2 macrophage polarization, thereby demonstrating substantial potential to remodel the immune microenvironment. Based on this, CA was employed as a bioactive structural building block, together with 4-aminophenylboronic acid (APBA), to construct a stimuli-responsive hydrogel (CAP hydrogel). The hydrogel not only exhibited self-healing ability and cytocompatibility (cell viability ~95%), but also achieved 82.48% of pH/ROS-responsive CA release, with accelerated release under acidic and ROS-rich conditions that mimic inflammatory wounds. This targeted responsiveness is expected to enhance on-demand local CA availability during the early inflammatory phase, thereby strengthening PGP-1 inhibition and immune microenvironment remodeling. In the deep burn wound model, the CAP hydrogel significantly accelerated wound closure and improved angiogenesis after 20 days of treatment. In addition, it promoted favorable remodeling of the local immune microenvironment by downregulating PGP-1 and related inflammatory signaling pathways. Overall, this study provides a feasible strategy for promoting wound healing through PGP-1 inhibition and immune microenvironment modulation. It also presents a functional hydrogel with translational potential for advanced wound care and regenerative medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.